TY - JOUR
KW - Humans
KW - *Pulmonary Disease, Chronic Obstructive/diagnosis/drug therapy/chemically induced
KW - Cohort Studies
KW - *Diabetes Mellitus, Type 2/diagnosis/drug therapy/chemically induced
KW - Adrenal Cortex Hormones/adverse effects
KW - *Cerebrovascular Disorders
KW - Copd
KW - chronic obstructive pulmonary disease
KW - Cohort study
KW - corticosteroids
KW - observational
KW - primary care
AU - G. Tse
AU - B. Emmanuel
AU - C. Ariti
AU - M. Bafadhel
AU - A. Papi
AU - V. Carter
AU - J. Zhou
AU - D. Skinner
AU - X. Xu
AU - H. Mullerova
AU - D. Price
AD - Observational and Pragmatic Research Institute, Singapore, Singapore.
School of Nursing and Health Studies, Hong Kong Metropolitan University, Hong Kong, People's Republic of China.
AstraZeneca, Gaithersburg, MD, USA.
Department of Immunobiology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Respiratory Medicine, Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
AstraZeneca, Cambridge, UK.
Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
AN - 38022830
BT - Int J Chron Obstruct Pulmon Dis
C2 - PMC10657769
DO - 10.2147/copd.s433326
DP - NLM
ET - 2023/11/29
LA - eng
N1 - 1178-2005
Tse, Gary
Orcid: 0000-0001-5510-1253
Emmanuel, Benjamin
Orcid: 0000-0003-1769-9826
Ariti, Cono
Orcid: 0000-0001-7615-0935
Bafadhel, Mona
Orcid: 0000-0002-9993-2478
Papi, Alberto
Orcid: 0000-0002-6924-4500
Carter, Victoria
Orcid: 0000-0002-0333-3308
Zhou, Jiandong
Orcid: 0000-0003-3780-9033
Skinner, Derek
Orcid: 0000-0002-7112-9317
Xu, Xiao
Müllerová, Hana
Orcid: 0000-0002-0949-0101
Price, David
Orcid: 0000-0002-9728-9992
Journal Article
Observational Study
New Zealand
Int J Chron Obstruct Pulmon Dis. 2023 Nov 15;18:2565-2580. doi: 10.2147/COPD.S433326. eCollection 2023.
PY - 2023
SN - 1176-9106 (Print)1176-9106
SP - 2565
EP - 2580
T2 - Int J Chron Obstruct Pulmon Dis
TI - A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD
VL - 18
ER -